GLP1R and Alzheimer disease: Besides, metformin has been shown to ameliorate neuronal insulin resistance in an in vitro neuronal insulin-resistant model also showing hallmark AD-like changes [22] and to inhibit neuronal damage by upregulating GLP-1 receptor (GLP1R) [23].